Hidroxizina [Inn-Spanish] en es it fr

Hidroxizina [Inn-Spanish] Brand names, Hidroxizina [Inn-Spanish] Analogs

Hidroxizina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Hidroxizina [Inn-Spanish] Chemical_Formula


Hidroxizina [Inn-Spanish] RX_link


Hidroxizina [Inn-Spanish] fda sheet

Hidroxizina [Inn-Spanish] msds (material safety sheet)

Hidroxizina_[Inn-Spanish] MSDS

Hidroxizina [Inn-Spanish] Synthesis Reference

Moren; U.S. Pat. 2,899,436 (1959)

Hidroxizina [Inn-Spanish] Molecular Weight

374.904 g/mol

Hidroxizina [Inn-Spanish] Melting Point

190 oC

Hidroxizina [Inn-Spanish] H2O Solubility

< 700 mg/mL

Hidroxizina [Inn-Spanish] State


Hidroxizina [Inn-Spanish] LogP


Hidroxizina [Inn-Spanish] Dosage Forms

Capsule; Liquid; Solution; Syrup

Hidroxizina [Inn-Spanish] Indication

For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria.

Hidroxizina [Inn-Spanish] Pharmacology

Hydroxyzine, a piperazine antihistamine structurally related to buclizine, cyclizine, and meclizine, is used to treat histamine-mediated pruritus or pruritus due to allergy, nausea and vomiting, and, in combination with an opiate agonist, anxiolytic pain. Hydroxyzine is also used as a perioperative sedative and anxiolytic and to manage acute alcohol withdrawal. Hydroxyzine's active metabolite, cetirizine, is also used as an H1-antagonist.

Hidroxizina [Inn-Spanish] Absorption

Rapidly absorbed from the gastrointestinal tract

Hidroxizina [Inn-Spanish] side effects and Toxicity

Oral, rat LD50: 950 mg/kg. Symptoms of overexposure include hypersedation.

Hidroxizina [Inn-Spanish] Patient Information

Hidroxizina [Inn-Spanish] Organisms Affected

Humans and other mammals